An Eleven-Year Retrospective Study of Endogenous Bacterial Endophthalmitis

• Published in: Journal of Ophthalmology Vol. 2015; no. 2015; pp. 401 - 411
• Main Authors: Mochizuki, Kiyofumi, Kawakami, Hideaki, Niwa, Yoshiaki, Ishida, Kyoko, Nishida, Takashi, Ohkusu, Kiyofumi
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Limiteds 01-01-2015; Hindawi Publishing Corporation; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Abscesses; Bacterial infections; Blood; Care and treatment; Catheters; Colorectal cancer; Diabetes; Diagnosis; Disease; Endocarditis; Endophthalmitis; Hemodialysis; Hospitals; Hypertension; Liver; Medical records; Nosocomial infections; Pain; Patient outcomes; Patients; Peritonitis; Physiological aspects; Pneumonia; Staphylococcus aureus; Urinary tract diseases; Urinary tract infections; Urogenital system; Japan
• ISSN: 2090-004X; 2090-0058
• DOI: 10.1155/2015/261310

Purpose. To determine the clinical features, microbial profiles, treatment outcomes, and prognostic factors for endogenous bacterial endophthalmitis (EBE). Methods. The medical records of 27 eyes of 21 patients diagnosed with EBE for 11 years were reviewed. Collected data included age, site of infection, visual acuities (VAs), microbial profiles, and treatment regimen. Results. The mean age was 68.5 years. Gram-positive organisms accounted for 76.2%, while gram-negative ones accounted for 19.0%. Staphylococcus aureus was the most common causative organism (52.3%) of which 72.7% was methicillin-resistant S. aureus. A final VA of ≥20/40 was achieved in 44% and 20/200 or better was in 64%. Eyes with initial VA of ≥20/200 ( P = 0.003) and focal involvements ( P = 0.011) had significantly better final VA. Initial VA ( P = 0.001) and the interval between onset of ocular symptoms and intravitreal antibiotic injection ( P = 0.097) were associated with final VA in eyes receiving intravitreal antibiotics. Conclusions. EBE is generally associated with poor visual outcome; however the prognosis may depend on initial VA, extent of ocular involvement, and an interval between onset of ocular symptoms and intravitreal antibiotic injection. Early diagnosis and early intravitreal injection supplement to systemic antibiotics might lead to a relatively good visual outcome.